National Cancer Institute   Cancer Therapy Evaluation Program   Developing Cancer Therapies
CTEP HomeContactHelpSearch:


CTEP Highlights

Dear Investigators:
As we have become aware that ASCO has recently notified investigators concerning acceptances of abstracts for presentations ( posters or oral ) would like to remind you of your obligation to submit theses presentations in advance of the meeting to CTEP so that we may forward them to the relevant pharmaceutical company collaborators.

Your cooperation will be appreciated.

You should send presentations to:

Regulatory Affairs Branch, CTEP, DCTD, NCI
Executive Plaza North, Suite 7111
Bethesda, MD 20892
FAX 301-402-1584
E-mail: anshers@ctep.nci.nih.gov

6/3/2004 - RNA Interference — Target Validation & Potential Therapeutic Applications for Childhood Cancer

4/8/2004 - Revised template for review of your informed consent documents as of June 1, 2004


  Home   |   Contact   |   Privacy Notice   |   Accessibility National Cancer Institute   National Institutes of Health   Department of Health and Human Services   USA.gov